サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Orthobiologics Market Research Report - Global Forecast till 2024

世界のオーソバイオロジクス市場調査レポート‐2024年までの世界予測

レポート概要

世界のオーソバイオロジクス市場調査レポート:製品別(脱灰骨基質、骨形成タンパク質)用途別(変形性関節症&変性性関節炎、脊椎固定術)、エンドユーザー別(病院、整形外科クリニック)‐2024年までの世界予測

市場シナリオ

世界のオーソバイオロジクス市場は2019年に49億6,400万ドルに達し、予測期間中(2019-2024)のCAGRは5.6%と予想されます。オーソバイオロジクスは整形外科医が外傷をより迅速に治癒させるために使用する物質で、腱や靭帯の改善、骨折の治癒、筋障害に使用されます。これらの製品は人体由来の物質であり、より高密度で使用すると治癒速度を速めるのに有効です。

予測期間中は外傷やスポーツ外傷患者の増加、低侵襲的手術における生物製剤の需要、製品の承認、認知度の向上が世界のオーソバイオロジクス市場の成長を促すでしょう。さらに、バイオマテリアルにおける新しい技術革新、肥満&高齢者人口の増加、新製品の開発に向けた合併や事業拡大、連携といったトッププレイヤーによる研究開発活動の活発化、主要メーカーによる製品の発売などもこの市場の成長を加速させています。

例えば、米国商務省のデータによると、2015年には60歳以上の総人口は9億9,124万人、2018年には9億9,124万人に達し、60歳以上の人口の増加率は毎年3.18%となっています。一方で、保険適用の狭さが成長の妨げとなります。

レポート詳細

目次

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation

Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators

Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis

Chapter 6. Global Orthobiologics Market, by Product
6.1. Introduction
6.2. Demineralized bone matrix (DBM)
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
6.3. Bone morphogenetic protein (BPM)
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
6.4. Allograft
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
6.5. Viscosupplementation products
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
6.6. Synthetic bone substitutes
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
6.7. Others

Chapter 7. Global Orthobiologics Market, by Application
7.1. Introduction
7.2. Osteoarthritis & degenerative arthritis
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
7.3. Spinal fusion
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
7.4. Fracture recovery
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
7.5. Soft tissue injuries
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
7.6. Others

Chapter 8. Global Orthobiologics Market, by End User
8.1. Introduction
8.2. Hospitals
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
8.3. Orthopedic Clinics
Market Estimates & Forecast, by Region, 2019-2024
Market Estimates & Forecast, by Country, 2019-2024
8.4. Others

Chapter 9. Global Orthobiologics Market, by Region
9.1. Introduction
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa

Chapter 10. Company Landscape
10.1. Introduction
10.2. Market Share Analysis
10.3. Key Developments & Strategies

Chapter 11. Company Profiles
11.1. Arthrex, Inc.
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Exactech, Inc.
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Globus Medical Inc
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Integra LifeSciences
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Johnson & Johnson
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Medline Industries, Inc
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. NuVasive, Inc.
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Stryker Corporation
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Wright Medical Group N.V.
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Zimmer Biomet
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Others

Chapter 12. MRFR Conclusion
12.1. Key Findings
12.1.1. From CEO’s Viewpoint
12.1.2. Unmet Needs of the Market
12.2. Key Companies to Watch
12.3. Predictions for the Orthobiologics Industry

Chapter 13. Appendix

LIST OF TABLES
Table 1. Global Orthobiologics Market Synopsis, 2019-2024
Table 2. Global Orthobiologics Market Estimates and Forecast, 2019-2024 (USD Million)
Table 3. Global Orthobiologics Market, by Region, 2019-2024 (USD Million)
Table 4. Global Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 5. Global Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 6. Global Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 7. North America: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 8. North America: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 9. North America: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 10. US: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 11. US: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 12. US: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 13. Canada: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 14. Canada: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 15. Canada: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 16. Latin America: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 17. Latin America: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 18. Latin America: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 19. Europe: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 20. Europe: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 21. Europe: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 22. Western Europe: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 23. Western Europe: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 24. Western Europe: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 25. Eastern Europe: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 26. Eastern Europe: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 27. Eastern Europe: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 28. Asia-Pacific: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 29. Asia-Pacific: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 30. Asia-Pacific: Orthobiologics Market, by End User, 2019-2024 (USD Million)
Table 31. Middle East & Africa: Orthobiologics Market, by Product, 2019-2024 (USD Million)
Table 32. Middle East & Africa: Orthobiologics Market, by Application, 2019-2024 (USD Million)
Table 33. Middle East & Africa: Orthobiologics Market, by End User, 2019-2024 (USD Million)

LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Orthobiologics Market
Figure 3. Segmentation Market Dynamics for Global Orthobiologics Market
Figure 4. Global Orthobiologics Market Share, by Product, 2018
Figure 5. Global Orthobiologics Market Share, by Application, 2018
Figure 6. Global Orthobiologics Market Share, by End User, 2018
Figure 7. Global Orthobiologics Market Share, by Region, 2018
Figure 8. North America: Orthobiologics Market Share, by Country, 2018
Figure 9. Europe: Orthobiologics Market Share, by Country, 2018
Figure 10. Asia-Pacific: Orthobiologics Market Share, by Country, 2018
Figure 11. Middle East & Africa: Orthobiologics Market Share, by Country, 2018
Figure 12. Global Orthobiologics Market: Company Share Analysis, 2018 (%)
Figure 13. Arthrex, Inc.: Key Financials
Figure 14. Arthrex, Inc.: Segmental Revenue
Figure 15. Arthrex, Inc.: Geographical Revenue
Figure 16. Exactech, Inc.: Key Financials
Figure 17. Exactech, Inc.: Segmental Revenue
Figure 18. Exactech, Inc.: Geographical Revenue
Figure 19. Globus Medical Inc: Key Financials
Figure 20. Globus Medical Inc: Segmental Revenue
Figure 21. Globus Medical Inc: Geographical Revenue
Figure 22. Integra LifeSciences: Key Financials
Figure 23. Integra LifeSciences: Segmental Revenue
Figure 24. Integra LifeSciences: Geographical Revenue
Figure 25. Johnson & Johnson: Key Financials
Figure 26. Johnson & Johnson: Segmental Revenue
Figure 27. Johnson & Johnson: Geographical Revenue
Figure 28. Medline Industries, Inc: Key Financials
Figure 29. Medline Industries, Inc: Segmental Revenue
Figure 30. Medline Industries, Inc: Geographical Revenue
Figure 31. NuVasive, Inc.: Key Financials
Figure 32. NuVasive, Inc.: Segmental Revenue
Figure 33. NuVasive, Inc.: Geographical Revenue
Figure 34. Stryker Corporation: Key Financials
Figure 35. Stryker Corporation: Segmental Revenue
Figure 36. Stryker Corporation: Geographical Revenue
Figure 37. Wright Medical Group N.V.: Key Financials
Figure 38. Wright Medical Group N.V.: Segmental Revenue
Figure 39. Wright Medical Group N.V.: Geographical Revenue
Figure 40. Wright Medical Group N.V.: Key Financials
Figure 41. Wright Medical Group N.V.: Segmental Revenue
Figure 42. Wright Medical Group N.V.: Geographical Revenue

発刊日

2019/05

体裁

PDF / 90ページ

販売価格

4,450USD

発行

Market Research Future

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

疾病別治療・領域別治療 / 医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE